Monitor Power Backup Systems Regularly for GMP Critical Equipment

Monitor Backup Power Systems to Protect GMP Critical Operations

Remember: GMP mandates regular monitoring and maintenance of power backup systems for critical equipment to prevent operational disruptions and data loss.

Why This Matters in GMP

In pharmaceutical manufacturing, uninterrupted power supply is essential to maintain critical equipment such as refrigerators, HVAC systems, incubators, stability chambers, and electronic data capture systems. Power failure without a functional backup system can result in temperature excursions, batch loss, data corruption, and even environmental breaches. Backup systems such as Uninterruptible Power Supplies (UPS), diesel generators, and battery banks must be maintained and tested routinely. Inadequate power backup can severely impact product quality, regulatory compliance, and business continuity.

Also Read: The Impact of TGA GMP Compliance on Pharmaceutical Product Development

Regulatory and Compliance Implications

FDA 21 CFR Part 211.63 and 211.68 require that facilities and automated systems be adequately supported and maintained. EU GMP Chapter 3 states that all facilities must be designed to prevent failure during routine and emergency conditions. WHO GMP and Schedule M emphasize the need for reliable power systems, including secondary sources for critical infrastructure. Auditors expect to see documented preventive maintenance, validation of power systems, and alarm system testing. Failure to maintain power backups may result in data

integrity issues, product failures, or severe compliance findings.

Implementation Best Practices

Schedule regular load testing and calibration of all UPS and generator systems supporting GMP equipment.
Document all maintenance, battery replacements, and alarm tests in equipment logs.
Ensure power backup systems are linked with temperature monitoring, EM systems, and automated alerts.
Develop contingency SOPs for power failure events, including roles and responsibilities.
Verify that critical equipment connected to backup systems is clearly labeled and tested during validation.

Also Read: How to Use Failure Mode and Effects Analysis (FMEA) in GMP Risk Management

Regulatory References

FDA 21 CFR Part 211.63 & 211.68 – Equipment Design and Automatic Systems
EU GMP Chapter 3 – Premises and Equipment Requirements
WHO GMP – Utility Systems and Power Supply Controls
Schedule M – Backup Power and Risk Management